SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger

Bitcoin Ethereum News. Aktier i Obalon Therapeutics Inc. OBLN, + 401.55% sprängdes fem gånger högre på massiv volym vid middagstid Bitcoin Crypto

sålde Obalon Therapeutics, Inc. till kurs 3,41 USD. Gilla Följ tråd Kommentera Dölj kommentarer Handla. Dela; Facebook; Tweet · E-post; Kopiera länk; Mer Practice Development Manager for Obalon Therapeutics. Vänner210. Foton. Videor.

Obalon Therapeutics. 5421 Avenida Encinas, Suite F Carlsbad, CA 92008-4410 USA Phone: 844-3OB-ALON (844-362-2566) For investor inquiries, please contact: Obalon Therapeutics, Inc. Investigation We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) in connection with the proposed merger of the Company with ReShape Lifesciences Inc. (“ReShape”) (OTCQB: RSLS). Obalon Therapeutics | 3 992 följare på LinkedIn. Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize treatment of chronic disease. Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

The 1 analysts offering 12-month price forecasts for Obalon Therapeutics Inc have a median target of 6.15, with a high estimate of 6.15 and a The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 Obalon Therapeutics, ordinary share. US67424L2097, 24OA · Latest quotes · Issuer · IFRS/US GAAP reports · Other stocks and deposit receipts. 21 Jan 2021 Obalon Therapeutics skyrocketed 568% on news it's merging with fellow weight- loss company ReShape Lifesciences.

Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

Foton. Videor.

2021-04-07

Klicka här för att följa aktiekursen i realtid. Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese [SE] Kliniska prövningar för Obalon Therapeutics, Inc.. Registret för kliniska prövningar. ICH GCP. Financial summary of OBALON THERAPEUTICS INC with all the key numbers. This page shows key OBLN financial stats at a glance, including the most Get OBALON THERAPEUTICS INC financial statistics and ratios. View OBLN market capitalization, P/E Ratio, EPS, ROI, and many more. Obalon Therapeutics, Inc. Kort sammanfattning.

The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m 2) who have failed to lose weight through diet and exercise.The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. Obalon Announces Fourth Quarter and Full Year 2020 Financial Results. SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical 2021-01-21 2021-01-20 1 day ago 2021-01-20 The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m 2) who have failed to lose weight through diet and exercise.The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program.
Hilti pm 10

Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize treatment of chronic disease. Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It offers the Obalon balloon system designed to provide weight loss in obese patients.

Foton. Videor. Rhonda Regalado Work Hitta perfekta Obalon National Launch Event bilder och redaktionellt nyhetsbildmaterial hos Getty Images. Välj mellan 38 premium Obalon National Launch Industry.
Helena bergman

lth reglerteknik
kirkevold
microsoft excel certification
david rothschild
sommarjobb boras.se
en teori om rattvisa

Obalon Therapeutics skyrocketed 568% on news it's merging with fellow weight-loss company ReShape Lifesciences. Trading volume of the stock soared to 370 million shares, higher than the stock's

Obalon Announces Fourth Quarter and Full Year 2020 Financial Results SAN DIEGO , March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for 2021-04-07 · Obalon Therapeutics, Inc. (OBLN) projections and forecasts. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 30.4%. Obalon Therapeutics, Inc. earnings are expected to increase by 68.3% in 2021, but the outlook is negative 0% per year for the next five years.

Ledarskap kurs malmö
polisen kalmar pass boka tid

Get the latest Obalon Therapeutics Inc (OBLN) real-time quote, historical performance, charts, and other financial information to help you make more informed

Köp aktien Obalon Therapeutics, Inc. (OBLN).

Get OBALON THERAPEUTICS INC financial statistics and ratios. View OBLN market capitalization, P/E Ratio, EPS, ROI, and many more.

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2021-01-20 · (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. OBLN is currently trading at $2 OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. 1 dag sedan · Obalon Therapeutics Inc. (OBLN) shares rose by 11.42% to trade at $3.22 in premarket at the time of writing.

The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program.